Orlando, FL 1/17/12 (StreetBeat) -- D. Medical Industries Ltd. (Nasdaq:DMED), a medical device company engaged through its subsidiaries in the research, development, manufacture and sale of innovative products for diabetes treatment and drug delivery, announced today that its subsidiary, Spring Health Solutions Inc. ("Spring Health"), has signed a non-exclusive agreement with Better Living Now Inc. ("BLN") for distribution of its Spring(TM) Universal Infusion Sets in the United States.
The agreement has an initial term of two years, commencing on the date of BLN's initial order, and will thereafter be automatically renewed for one-year periods. In addition, each party may terminate the agreement upon three months prior written notice to the other party.
The U.S. insulin pump and disposables market is large and growing. According to the American Diabetes Association, approximately 26 million diabetes patients live in the United States, constituting 8.3% of its population. Of those, experts estimate that 5.4%, or 1.4 million, suffer from Type 1 diabetes and 350,000 currently rely on insulin pump therapy. A recent U.S. Centers for Disease Control and Prevention report estimated that 1 in 3 Americans will have diabetes by 2050 if current trends continue. The annual market for infusion sets alone in the U.S. is estimated to total $730 million.
Efri Argaman, D. Medical's Chief Executive Officer, commented, "We are pleased to enter into this relationship with BLN, a company that shares D. Medical's commitment to customer care and that has a strong presence in the U.S. diabetes distribution market. As patient interest in ground-breaking new products for diabetes management, like the Spring Universal Infusion Set, continues to grow, expanding our distribution network is key to gaining greater market access. Accordingly, the signing of this, our fourth distribution agreement in the U.S., is a key milestone achievement for our Company. We look forward to building a successful long-term working relationship with BLN."
StreetBeat Disclaimer
No comments:
Post a Comment